| |
| Ablazione transcatetere mediante criopallone per il trattamento della fibrillazione atriale. Valutazione rapida [Trancatheter ablation with cryoballoon for the treatment of atrial fibrillation. A rapid assessment] |
| Negro A, Maltoni S, Pecoraro V, Camerlingo M, Falasca G, Lauretti F. |
|
|
| |
Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Negro A, Maltoni S, Pecoraro V, Camerlingo M, Falasca G, Lauretti F.. Ablazione transcatetere mediante criopallone per il trattamento della fibrillazione atriale. Valutazione rapida. [Trancatheter ablation with cryoballoon for the treatment of atrial fibrillation. A rapid assessment] Bologna: Agenzia sanitaria e sociale regionale, Regione Emilia-Romagna (ASSR). Authors' objectives The objective of the present assessment was to assess efficacy, safety, and technical performance of percutaneous ablation with cryoballoon in comparison to radiofrequency ablation for pulmonary vein isolation in patients with paroxysmal and persistent atrial fibrillation.
Percutaneous ablation with cryoballoon could offer advantages in terms of: identification and mapping of target sites (a reversible cryomapping is possible), reduction of catheter time in the left atrium (leading to a possible reduction of procedural complications), reduced procedural and fluoroscopy time with increased efficiency and, finally, relative simplicity of the procedure with a shorter learning curve.
Authors' conclusions Most of the studies assessed the first-generation cryoballoon (Arctic FrontTM, Medtronic Inc, Minneapolis, MN) to treat paroxysmal atrial fibrillation.
For this indication, cryoballoon ablation does not seem to be more effective than radiofrequency ablation in terms of recurrence of atrial fibrillation; cryoballoon ablation is associated with a significantly lower incidence of pericardial effusion and cardiac tamponade but with a higher risk of phrenic nerve injury (PNI) at hospital discharge. Furthermore, it was associated with a reduced procedural time.
Only two studies assessed the use of cryoballoon ablation in persistent atrial fibrillation.
MeSH Atrial Fibrillation; Catheter Ablation; Cryosurgery; Humans Language Published Italian Country of organisation Italy English summary An English language summary is available. Address for correspondence Viale Aldo Moro 21, 40127 Bologna, Italia tel. +39 051 5277165 fax +39 051 5277049 Email: Susanna.Maltoni@regione.emilia-romagna.it AccessionNumber 32017000453 Date abstract record published 11/12/2017 |
| |
|
|
